Concepedia

Adam Kesingland

AK

8

Publications

1.2K

Citations

8

H-Index

1990

Active since

Affiliations

Novartis (United Kingdom)(Current)

Novartis (Switzerland)

Adam Kesingland is an author at Novartis (United Kingdom) specializing in neuropathic pain, medicine, and pain research.

Top concepts

Publications per year

1990–2007

8

Publications

8

The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain

Alyson Fox, Adam Kesingland, Clive Gentry et al. · Pain · 2001 · 376 citations

The effects of GABAB agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat

Sadhana Patel, Sami Naeem, Adam Kesingland et al. · Pain · 2001 · 212 citations

Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function

Katherine Walker, M. Bowes, Moh Panesar et al. · Neuropharmacology · 2001 · 165 citations

, , +7

Comparative activity of the anti-convulsants oxcarbazepine, carbamazepine, lamotrigine and gabapentin in a model of neuropathic pain in the rat and guinea-pig

Alyson Fox, Clive Gentry, Sadhana Patel et al. · Pain · 2003 · 101 citations

Disease modifying and anti-nociceptive effects of the bisphosphonate, zoledronic acid in a model of bone cancer pain

Katharine Walker, Stephen J. Medhurst, Bruce Kidd et al. · Pain · 2002 · 97 citations

Rows per page

1–5 of 8